EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C12H19N3O |
| Net Charge | 0 |
| Average Mass | 221.304 |
| Monoisotopic Mass | 221.15281 |
| SMILES | CNNCc1ccc(C(=O)NC(C)C)cc1 |
| InChI | InChI=1S/C12H19N3O/c1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3/h4-7,9,13-14H,8H2,1-3H3,(H,15,16) |
| InChIKey | CPTBDICYNRMXFX-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| procarbazine (CHEBI:71417) has role antineoplastic agent (CHEBI:35610) |
| procarbazine (CHEBI:71417) is a benzamides (CHEBI:22702) |
| procarbazine (CHEBI:71417) is a hydrazines (CHEBI:24631) |
| procarbazine (CHEBI:71417) is conjugate base of procarbazine(1+) (CHEBI:71431) |
| Incoming Relation(s) |
| procarbazine(1+) (CHEBI:71431) is conjugate acid of procarbazine (CHEBI:71417) |
| IUPAC Name |
|---|
| N-(1-methylethyl)-4-[(2-methylhydrazino)methyl]benzamide |
| INNs | Source |
|---|---|
| procarbazine | KEGG DRUG |
| procarbazina | DrugBank |
| procarbazinum | DrugBank |
| procarbazine | WHO MedNet |
| Synonyms | Source |
|---|---|
| Procarbazin | DrugBank |
| 2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine | ChemIDplus |
| 4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide | ChemIDplus |
| N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide | ChemIDplus |
| N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide | ChemIDplus |
| N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| C07402 | KEGG COMPOUND |
| D08423 | KEGG DRUG |
| DB01168 | DrugBank |
| US3830840 | Patent |
| US2008107661 | Patent |
| US2007122414 | Patent |
| US3520926 | Patent |
| BE618638 | Patent |
| HMDB0015299 | HMDB |
| Procarbazine | Wikipedia |
| LSM-2272 | LINCS |
| 2272 | DrugCentral |
| Citations |
|---|